A previous study indicated that PD-L2 knockdown inhibits the ability of osteosarcoma cells to metastasize by the RhoA-ROCK-LIMK2 signaling pathway (11); thus, we further investigated the effect of VEGFR2 inhibition on RhoA-ROCK-LIMK2 signaling. The gene discussed is RHOA; the disease is osteosarcoma.